Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.52 is 28% above its 5-year average of -0.73, near the high end of its 5-year range (-1.59–-0.14).
22.96% above its 12-month average of -0.68.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.10.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.52
EARNINGS PER SHARE (EPS) AVG TTM
-0.68
EARNINGS PER SHARE (EPS) AVG 3Y
-0.92
EARNINGS PER SHARE (EPS) AVG 5Y
-0.73
EARNINGS PER SHARE (EPS) AVG 10Y
-0.15
EARNINGS PER SHARE (EPS) AVG 15Y
-0.51
EARNINGS PER SHARE (EPS) AVG 20Y
-0.45
CURRENT VS TTM AVG
+22.96%
CURRENT VS 3Y AVG
+43.17%
CURRENT VS 5Y AVG
+28.44%
CURRENT VS 10Y AVG
-256.32%
CURRENT VS 15Y AVG
-1.12%
CURRENT VS 20Y AVG
-16.31%
HeartBeam, Inc.
Market Cap
$32.31M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.68
3Y Avg
-0.92
5Y Avg
-0.73
Market Cap
$32.76M
Earnings Per Share (EPS)
-2.56
TTM Avg
-5.45
3Y Avg
-15.27
5Y Avg
-9.79
Market Cap
$32.14M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.24
3Y Avg
-0.01
5Y Avg
0.39
Market Cap
$31.77M
Earnings Per Share (EPS)
0.37
TTM Avg
-0.28
3Y Avg
0.68
5Y Avg
0.80
Market Cap
$31.05M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.42
3Y Avg
-0.82
5Y Avg
-1.14
Market Cap
$31.20M
Earnings Per Share (EPS)
-1.38
TTM Avg
-0.93
3Y Avg
-0.75
5Y Avg
-0.52
Market Cap
$31.02M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.73
3Y Avg
-1.47
5Y Avg
-1.95
Market Cap
$30.61M
Earnings Per Share (EPS)
-0.17
TTM Avg
-0.24
3Y Avg
-0.47
5Y Avg
-0.92
Market Cap
$33.93M
Earnings Per Share (EPS)
-7.30
TTM Avg
-11.70
3Y Avg
-7.29
5Y Avg
-5.93
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartBeam, Inc. (BEAT) | $32.31M | -0.52 | -0.68 | -0.92 | -0.73 |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | -2.56 | -5.45 | -15.27 | -9.79 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.14M | N/A | -0.24 | -0.01 | 0.39 |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 0.37 | -0.28 | 0.68 | 0.80 |
| Context Therapeutics Inc. (CNTX)vs › | $31.05M | -0.48 | -0.42 | -0.82 | -1.14 |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.20M | -1.38 | -0.93 | -0.75 | -0.52 |
| MDxHealth S.A. (MDXH)vs › | $31.02M | N/A | -0.73 | -1.47 | -1.95 |
| BeyondSpring Inc. (BYSI)vs › | $30.61M | -0.17 | -0.24 | -0.47 | -0.92 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.93M | -7.30 | -11.70 | -7.29 | -5.93 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.34M | -1.26 | -0.80 | -2.79 | -3.86 |
Trailing EPS (TTM)
$-0.52
Forward EPS (Est.)
$-0.38
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.62 |
| 2024-12-31 | -0.73 |
| 2023-12-31 | -0.72 |
| 2022-12-31 | -1.59 |
| 2021-12-31 | -0.56 |
| 2020-12-31 | -0.14 |
| 2019-12-31 | -0.10 |
| 2018-12-31 | 1.20 |
| 2017-12-31 | -0.53 |
| 2016-12-31 | 1.91 |
| 2015-12-31 | 0.27 |
| 2014-12-31 | -0.37 |
| 2013-12-31 | -0.29 |
| 2012-12-31 | -0.49 |
| 2011-12-31 | -2.51 |
| 2010-12-31 | -0.82 |
| 2009-12-31 | -0.86 |
| 2008-12-31 | 0.50 |
| 2007-12-31 | -0.02 |
| 2006-12-31 | -0.53 |
| 2005-12-31 | -4.04 |
| 2004-12-31 | -7.33 |
| 2003-12-31 | -5.23 |
